Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-01

FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Micardis (telmisartan) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval pertains to changes authoriz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)

Snippet

SUPPL AP for MICARDIS (TELMISARTAN)